$IMNM
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Healthcare
Sector
Biotechnology
Industry
Clay Siegall
CEO
131
Employees
$18.53
Current Price
$2.03B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 1 | $1,093,800.00 | 60,000 | ||
| 1 month | Buys | 1 | 3 | $204,260.00 | 10,500 | 1:6.35 |
| Sells | 2 | 3 | $1,297,620.00 | 70,500 | ||
| 2 months | Buys | 1 | 4 | $307,760.00 | 15,500 | 1:4.22 |
| Sells | 2 | 3 | $1,297,620.00 | 70,500 | ||
| 3 months | Buys | 1 | 4 | $307,760.00 | 15,500 | 1:9.51 |
| Sells | 3 | 6 | $2,926,774.40 | 144,938 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Rosett Max Chief Financial Officer | Sale | 60,000 | $18.23 | $1,093,800.00 | View Details |
| Jun 5, 2026 | BIENAIME JEAN JACQUES Director | Sale | 10,000 | $19.41 | $194,100.00 | View Details |
| Jun 5, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 6,000 | $19.48 | $116,880.00 | View Details |
| Jun 5, 2026 | BIENAIME JEAN JACQUES Director | Sale | 500 | $19.44 | $9,720.00 | View Details |
| Jun 5, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 3,500 | $19.46 | $68,110.00 | View Details |
| Jun 5, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 1,000 | $19.27 | $19,270.00 | View Details |
| May 15, 2026 | BIENAIME JEAN JACQUES Director | Purchase | 5,000 | $20.70 | $103,500.00 | View Details |
| Apr 2, 2026 | Higgins Jack Chief Scientific Officer | Sale | 9,438 | $21.64 | $204,238.32 | View Details |
| Apr 2, 2026 | Rosett Max Chief Financial Officer | Sale | 63,656 | $21.91 | $1,394,702.96 | View Details |
| Apr 2, 2026 | Rosett Max Chief Financial Officer | Sale | 1,344 | $22.48 | $30,213.12 | View Details |
| Mar 27, 2026 | SIEGALL CLAY B Director | Purchase | 25,450 | $19.67 | $500,601.50 | View Details |
10 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: